223 Interval training, resistance training with high repetitions, and circuit training are effective methods for building muscular endurance
Ozempic litigation is new and evolving
Safety Comparison Table# Research Evidence Comparison# MariTide Research# MariTide's key evidence comes from a phase 2 trial published in the New England Journal of Medicine (2025): Design: 592 participants across two cohorts -- obesity without T2D, and obesity with T2D -- over 52 weeks Obesity cohort: Mean weight loss ranged from -12.3% to -16.2% with MariTide vs -2.5% with placebo (up to 20% in some analyses) Obesity + T2D cohort: Mean weight loss ranged from -8.4% to -12.3% with MariTide vs -1.7% with placebo

Specific situations requiring GP discussion: Inadequate glycaemic control: If blood glucose remains elevated despite four weeks at current dose Hypoglycaemia: Particularly if taking sulfonylureas or insulin concurrently (dose adjustments of these medications may be needed) Significant weight loss: Unintended excessive weight reduction Planned surgery or acute illness: Temporary treatment modifications may be necessary Pregnancy planning: Ozempic should be discontinued at least two months before conception New medications: Potential drug interactions require review Visual changes: Especially if you have pre-existing diabetic retinopathy Symptoms of gallbladder disease: Persistent right upper abdominal pain, fever, or jaundice Never adjust your Ozempic dose independently or discontinue treatment without medical guidance
Ensure adequate intake of iodine (found in dairy, fish, and eggs) and selenium (Brazil nuts, fish, eggs), which are important for thyroid hormone synthesis
Mild nausea or slight changes in digestion may remain, though usually at much lower intensity than initial onset